Besides the intragenic deletions, a large 204 kbp duplication on chromosome 5 (chr5:65111984—65316190) resulted in the formation of the NLN–ERBB2IP fusion gene, which has been associated with breast invasive carcinoma [32]. The gene discussed is NLN; the disease is invasive breast carcinoma.